These compounds may interact with:
Calpain-1 catalytic subunit
Potentially involved in: neurodegenerative disease; hereditary spastic paraplegia; carcinoma; mucoepidermoid carcinoma; presbyopia; melanoma; optic neuritis; atopic dermatitis; atypical teratoid / rhabdoid tumor; diabetes mellitus; interstitial cystitis; osteosarcoma; neoplasms; spastic paraplegia 76, autosomal recessive
Disease data sourced from Pharos.